Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-oxypyrrolidin-1-yl)-n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)acetoamide
2. Mkc 231
3. Mkc-231
1. 135463-81-9
2. N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
3. Mkc-231
4. Bci-540
5. Coluracetam [inn]
6. V6fl6o5gr7
7. 2-(2-oxypyrrolidin-1-yl)-n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)acetoamide
8. N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
9. N-{2,3-dimethyl-5h,6h,7h,8h-furo[2,3-b]quinolin-4-yl}-2-(2-oxopyrrolidin-1-yl)acetamide
10. Unii-v6fl6o5gr7
11. Mkc 231
12. Chembl37935
13. Schembl194780
14. Zinc4939
15. Dtxsid60159386
16. Ex-a739
17. Coluracetam;mkc-231;bci-540
18. Hms3886i15
19. Amy32492
20. Bcp07168
21. Mfcd00901416
22. S5222
23. Akos015842255
24. Ccg-267931
25. Ncgc00378715-01
26. Ac-31948
27. Ds-14004
28. Hy-17553
29. C3689
30. Ft-0697594
31. 463c819
32. A857829
33. J-690145
34. Q3683872
35. 1-pyrrolidineacetamide, 2-oxo-n-(5,6,7,8-tetrahydro-2,3-dimethylfuro(2,3-b)quinolin-4-yl)-
36. N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxo-1-pyrrolidinyl)acetamide
37. N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrroli Din-1-yl)acetamide
| Molecular Weight | 341.4 g/mol |
|---|---|
| Molecular Formula | C19H23N3O3 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 341.17394160 g/mol |
| Monoisotopic Mass | 341.17394160 g/mol |
| Topological Polar Surface Area | 75.4 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 540 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Mkc 231 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mkc 231, including repackagers and relabelers. The FDA regulates Mkc 231 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mkc 231 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mkc 231 supplier is an individual or a company that provides Mkc 231 active pharmaceutical ingredient (API) or Mkc 231 finished formulations upon request. The Mkc 231 suppliers may include Mkc 231 API manufacturers, exporters, distributors and traders.
click here to find a list of Mkc 231 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mkc 231 DMF (Drug Master File) is a document detailing the whole manufacturing process of Mkc 231 active pharmaceutical ingredient (API) in detail. Different forms of Mkc 231 DMFs exist exist since differing nations have different regulations, such as Mkc 231 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mkc 231 DMF submitted to regulatory agencies in the US is known as a USDMF. Mkc 231 USDMF includes data on Mkc 231's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mkc 231 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mkc 231 suppliers with USDMF on PharmaCompass.
Mkc 231 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mkc 231 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mkc 231 GMP manufacturer or Mkc 231 GMP API supplier for your needs.
A Mkc 231 CoA (Certificate of Analysis) is a formal document that attests to Mkc 231's compliance with Mkc 231 specifications and serves as a tool for batch-level quality control.
Mkc 231 CoA mostly includes findings from lab analyses of a specific batch. For each Mkc 231 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mkc 231 may be tested according to a variety of international standards, such as European Pharmacopoeia (Mkc 231 EP), Mkc 231 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mkc 231 USP).
LOOKING FOR A SUPPLIER?
